Crohn’s disease (CD) can eventually cause intestinal damage and impairment as a chronic inflammatory bowel disease with relapsing and remitting symptoms. Therefore, it is essential to get an early diagnosis and appropriate care. The terminal ileum and colon are the most often impacted areas of the gastrointestinal system by CD (Sulz et al., 2020). The patient is a 46 years old white woman with a smoking habit without chronic diseases. The reported symptoms include blood in the stool with mucus, fatigue, frequent diarrhea, loss of appetite, and tenesmus. The patient’s mucosal irritation was seen during the endoscopy. Budesonide or systemic oral corticosteroids are advised for moderately active localized ileocecal illness. The response to therapy will be clinically assessed after two weeks of medications.
The use of dietary therapy is also appropriate. Parenteral nutrition can enhance overall nutrition while enabling intestinal relaxation. It might be utilized as a short-term combination of nutrition therapy and pharmaceuticals, like immune system suppressors. A diet low in fiber and residue is also recommended to minimize the likelihood of intestinal blockage brought on by a constricted stricture (Sulz et al., 2020). The stools’ size and frequency will decrease if the patient follows a low-residue diet. It is also essential to stop smoking and create a healthy lifestyle plan. Procto-sigmoidoscopy should also be carried out to check for active luminal illness. It must be addressed to achieve and maintain recovery if it is found. The integration of surgical and medicinal therapy may have a more favorable healing impact on perianal fistulae than either procedure used alone, according to a comprehensive evaluation of diverse retrospective data. Case studies are the cornerstone of evidence-based therapy. Many medical professionals supplement standard induction therapy with a proton pump inhibitor.
References
Sulz, M. C., Burri, E., Michetti, P., Rogler, G., Peyrin-Biroulet, L., & Seibold, F. (2020). Treatment Algorithms for Crohn’s Disease. Digestion, 101(1), 43–57. Web.